A DNA scaffold that carries HIV vaccine proteins into the body sharpens the immune response against the virus.

The trial is taking place at the Desmond Tutu HIV Foundation, located at Groote Schuur Hospital in Cape Town. It is the first ...

A novel HIV vaccine candidate induces neutralising antibodies after a single dose in primates, potentially accelerating HIV prevention.

BRILLIANT 011 – the first-in-human HIV/AIDS vaccine trial in South Africa – is taking place at the Desmond Tutu HIV ...

South Africa’s efforts to develop an HIV vaccine reached a significant new phase this week, with the first participant officially enrolled in the BRILLIANT 011 first-in-human clinical trial at Groote ...

The injection is administered under the skin in the abdominal area by a healthcare provider and is designed to be discreet and convenient.

The Trump administration decided that it will no longer observe World AIDS Day. This is in contrast to the historical federal recognition of World AIDS Day under both Republican and ...

By Sharon AtienoSouth Africa has unveiled the first-in-human clinical trial of an HIV vaccine specifically targeting strains in Southern Africa.The Eastern and Southern Africa region carries the ...

A popular honeymoon destination is the site of the Pacific’s fastest-growing HIV epidemic, with officials pointing to rising meth use as a key driver.

South Africa has begun the first human trials of a locally developed HIV vaccine to defeat a virus that still kills around one person per minute worldwide.

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.